1 / 12

Technology Title One-line Description Name, PhD Title Department Rutgers University

Technology Title One-line Description Name, PhD Title Department Rutgers University Name2, PhD ; Title Name3, PhD ; Title. Introduction. “Elevator pitch” – a simple mission statement, no more than 2-3 sentences , that encapsulates:

everettp
Download Presentation

Technology Title One-line Description Name, PhD Title Department Rutgers University

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Technology Title • One-line Description • Name, PhD • Title • Department • Rutgers University • Name2, PhD; Title • Name3, PhD; Title

  2. Introduction • “Elevator pitch” – a simple mission statement, no more than 2-3 sentences, that encapsulates: • What your technology is and how it works, in “plain English”; • What specific problem it solves; • Why your technology is unique and superior; and • Who actually uses your product (if appropriate). • A picture or diagram of your technology, if appropriate. • This slide should be crafted for a generalist and non-scientist.

  3. Problem & Market Need • What is the unmet market need? What is the problem you are trying to solve? • What is the estimated market size specificto your technology?

  4. The Innovation - Summary • Visual display of your product/service. • What does it do? • How does it solve the market need? • Compareand contrast to current solutions/gold standard. • How is your solution unique? • What are the advantages? • What are the risks and dis-advantages?

  5. The Innovation - Details Part 1 • Describe one specific aspect or improvement that your technology offers (i.e., one aspect per slide). • Include supporting data, evidence, charts, as appropriate.

  6. The Innovation - Details Part 2(3 additional slides, max) • Describe a specific aspect / improvement that your technology offers. • Include supporting data, evidence, charts, as appropriate.

  7. Current Stage of Development • What is the IP/patent status? • Other than Rutgers, what other institution(s), if any, co-own(s) the technology? • What is the current stage of the technology? i.e., “Where are you today?” • E.g., “We achieved …” or “We discovered that …” • E.g., “Our lead compounds exhibit …” • E.g., “We have a working prototype that does ...” • E.g., “We are ready to perform …” • E.g., “We identified partners to help manufacture components of …” • This section should include a combination of the above, and serves as a segue to the next slide.

  8. Goals & Milestones – (See Next Slide for an example) • Near-term goals (next steps to validate commerciality) • Experiments, MVP (minimum viable product) • Customer discovery exercises • Gaps to be addressedwith current round of funding: • What will this funding help you achieve? • What meaningful results do you expect to generate? • What aspect of the technology are you “de-risking” (e.g., toxicity, efficacy, etc.) • Multi-year timeline of product development to commercialization. • E.g., pre-clinical, clinical, product launch. • What key research needs to be done at each stage? • What specifically are you “de-risking” at each stage? • How much (further) funding is likely required at each stage. (Optional) • This sub-section would be helpful if the tech requires materially different funding or timeline of development compared to “standard” regulatory processes. • Are there other broader potential fields of use or commercialization aspects for this technology?

  9. General Template for life-sciences. Please note that ALL the numbers and comments are placeholders, and should be modified to be directly relevant to your technology. Development Timeline & Funding Requirements Key Tasks & Milestones: • Discovery & Lead Optimization • In vivo testing: • Mice (n=12) • Efficacy • Dose range • Toxicity • Commentary on head-to-head comparison to gold standard • Large animal model • Pig (n=10) • Characterize production steps for lead compounds • CRO: candidate list and initiate contact • Other commentary • Pre-IND filing • IND-enabling studies • Establish GMP • Quality attributes • Engage CROs and CMOs • Other commentary • Phase 1 • Human trials (n=100-150) • General commentary 9-12 months Timeline: 2-3 years 6-12 months 12 months 2Q20 2Q21 3Q19 2Q22 Funding Required: $350K $20M+ $250K $3M Cumulative: $600K $3.6M $30M $250K (SBIR I, NIH, Angel/Seed) (SBIR II, Angel/Seed, VC) (VC) (VC / IPO) • Cumulative Funding To-Date: • NIH (2015 – 3Q 2019: $1M) • Rutgers TechAdvance (1Q 2019: $100K) Other Notables:

  10. The Team • Include pictures of team members, if appropriate. • If possible, highlight skillsets and knowledge base that are complementary. • An ideal team would have: Scientific expertise, Clinical expertise, Commercialization expertise. • Include a “Commercialization Track Record”, if any, as a separate slide: • A summary highlight of products that your team was directly involved with, that are currently (1) commercial, (2) in development, and/or (3) in clinical studies or use. • If you have a truly unique team and track record (successful commercialization, seasoned business founders, expert clinicians, etc.), this slide could be the first or second slide of the presentation.

  11. THANK YOU

  12. Appendix (multiple slides as appropriate) • More data and evidence supporting your technology. • More details on market size, segments of the market, and opportunity.

More Related